Joseph P Lyssikatos - Net Worth and Insider Trading
Joseph P Lyssikatos Net Worth
The estimated net worth of Joseph P Lyssikatos is at least $23 Million dollars as of 2024-12-26. Joseph P Lyssikatos is the CHIEF SCIENTIFIC OFFICER of Enliven Therapeutics Inc and owns about 1,015,188 shares of Enliven Therapeutics Inc (ELVN) stock worth over $23 Million. Details can be seen in Joseph P Lyssikatos's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joseph P Lyssikatos has not made any transactions after 2024-10-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Joseph P Lyssikatos
Joseph P Lyssikatos Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joseph P Lyssikatos owns 1 companies in total, including Enliven Therapeutics Inc (ELVN) .
Click here to see the complete history of Joseph P Lyssikatos’s form 4 insider trades.
Insider Ownership Summary of Joseph P Lyssikatos
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ELVN | Enliven Therapeutics Inc | 2024-10-18 | director & Chief Scientific Officer |
Joseph P Lyssikatos Latest Holdings Summary
Joseph P Lyssikatos currently owns a total of 1 stock. Joseph P Lyssikatos owns 1,015,188 shares of Enliven Therapeutics Inc (ELVN) as of October 18, 2024, with a value of $23 Million.
Latest Holdings of Joseph P Lyssikatos
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ELVN | Enliven Therapeutics Inc | 2024-10-18 | 1,015,188 | 22.71 | 23,054,919 |
Holding Weightings of Joseph P Lyssikatos
Joseph P Lyssikatos Form 4 Trading Tracker
According to the SEC Form 4 filings, Joseph P Lyssikatos has made a total of 19 transactions in Enliven Therapeutics Inc (ELVN) over the past 5 years, including 0 buys and 19 sells. The most-recent trade in Enliven Therapeutics Inc is the sale of 847 shares on October 18, 2024, which brought Joseph P Lyssikatos around $25,410.
Insider Trading History of Joseph P Lyssikatos
- 1
Joseph P Lyssikatos Trading Performance
Joseph P Lyssikatos Ownership Network
Joseph P Lyssikatos Owned Company Details
What does Enliven Therapeutics Inc do?
Who are the key executives at Enliven Therapeutics Inc?
Joseph P Lyssikatos is the director & Chief Scientific Officer of Enliven Therapeutics Inc. Other key executives at Enliven Therapeutics Inc include Chief Financial Officer Benjamin Hohl , director & President and CEO Samuel Kintz , and Chief Operating Officer Anish Patel .
Enliven Therapeutics Inc (ELVN) Insider Trades Summary
Over the past 18 months, Joseph P Lyssikatos made 19 insider transaction in Enliven Therapeutics Inc (ELVN) with a net sale of 239,847. Other recent insider transactions involving Enliven Therapeutics Inc (ELVN) include a net sale of 93,564 shares made by Benjamin Hohl , a net sale of 240,342 shares made by Samuel Kintz , and a net sale of 30,154 shares made by Richard A. Heyman .
In summary, during the past 3 months, insiders sold 157,819 shares of Enliven Therapeutics Inc (ELVN) in total and bought 0 shares, with a net sale of 157,819 shares. During the past 18 months, 4,860,959 shares of Enliven Therapeutics Inc (ELVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,860,959 shares.
Enliven Therapeutics Inc (ELVN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Enliven Therapeutics Inc Insider Transactions
Joseph P Lyssikatos Mailing Address
Above is the net worth, insider trading, and ownership report for Joseph P Lyssikatos. You might contact Joseph P Lyssikatos via mailing address: 6200 Lookout Road, Boulder Co 80301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
